<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24966953</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>02</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection">
<Journal>
<ISSN IssnType="Electronic">1936-2625</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<Issue>5</Issue>
<PubDate>
<Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>International journal of clinical and experimental pathology</Title>
<ISOAbbreviation>Int J Clin Exp Pathol</ISOAbbreviation>
</Journal>
<ArticleTitle>Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.</ArticleTitle>
<Pagination>
<MedlinePgn>2430-7</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Epstein-Barr Virus (EBV) is a herpesvirus usually infecting B-cells but may occasionally infect T- or natural killer (NK)-cells. EBV-associated T- or NK-cell lymphoproliferations represent a continuous spectrum of diseases ranging from asymptomatic infection, infectious mononucleosis (IM), to clonal and malignant lymphoproliferations including systemic EBV-positive T/NK-cell lymphoproliferative disease (EBV-T/NK-LPD) of childhood and hydroa-vacciniforme-like lymphoma of the skin. The clonal diseases are more prevalent in East Asia and exhibit overlapping clinical and pathological features with chronic active EBV infection. Here we report our experience on 10 cases of EBV-associated T-cell lymphoproliferation from Taiwan including five males and five females with a median age of 18 years old (range, 15-28). The most common clinical symptoms were fever, neck mass and hepatosplenomegaly. Eight of these patients showed elevated lactate dehydrogenase level and half of the patients had cytopenia. All patients had either elevated EBV antibody titers or increased serum EBV DNA levels. Five cases were clinically IM-like with polyclonal (3 cases) or clonal (2 cases) T-cell lymphoproliferation. Two patients each had chronic active EBV infection (CAEBV) and hemophagocytic lymphohistiocytosis (HLH). One patient had both CAEBV and HLH. One of the HLH patients with marrow infiltration by intra-sinusoidal large atypical lymphocytes experienced a fulminant course. In a median follow-up time of 21.5 months, seven patients were free of disease, one was alive with disease, and two died of disease in 31 and 3 months, respectively, despite chemotherapy. We confirmed a wide clinicopathological range of EVB-associated T-cell lymphoproliferation in Taiwan. Furthermore, monomorphic LPD and the single case with fulminant course as defined by Ohshima et al (Pathol Int 2018) as categories A3 and B, respectively, died of disease despite chemotherapy. Our report, the largest series in the recent decade from Taiwan, adds to the understanding of these rare diseases with variable clinical and histopathological presentations. </AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Ren-Ching</ForeName>
<Initials>RC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital Taichung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Sheng-Tsung</ForeName>
<Initials>ST</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Chi-Mei Medical Center, and Department of Nursing, National Tainan Institute of Nursing Tainan, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hsieh</LastName>
<ForeName>Yen-Chuan</ForeName>
<Initials>YC</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Chi-Mei Medical Center, and Department of Medical Laboratory Science and Biotechnology, Chung Hwa University of Medical Technology Tainan, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Huang</LastName>
<ForeName>Wan-Ting</ForeName>
<Initials>WT</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hsu</LastName>
<ForeName>Jeng-Dong</ForeName>
<Initials>JD</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Chung Shan Medical University Hospital and School of Medicine, Chung Shan Medical University Taichung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tseng</LastName>
<ForeName>Chih-En</ForeName>
<Initials>CE</Initials>
<AffiliationInfo>
<Affiliation>Department of Anatomic Pathology, Buddhist Dalin Tzu Chi Hospital Chiayi, Taiwan ; School of Medicine, Buddhist Tzu Chi University Hualien, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>Ming-Chung</ForeName>
<Initials>MC</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology, Department of Internal Medicine, Chang Gung Memorial Hospital-Kaohsiung Medical Center, and Chang Gung University College of Medicine Kaohsiung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hwang</LastName>
<ForeName>Wei-Shou</ForeName>
<Initials>WS</Initials>
<AffiliationInfo>
<Affiliation>Division of Hematology and Oncology, Department of Internal Medicine, Chung-Shan Medical University Hospital and School of Medicine, Chung-Shan Medical University Taichung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wang</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology and Laboratory Medicine, Taichung Veterans General Hospital Taichung, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chuang</LastName>
<ForeName>Shih-Sung</ForeName>
<Initials>SS</Initials>
<AffiliationInfo>
<Affiliation>Department of Pathology, Chi-Mei Medical Center Tainan, Taiwan ; Taipei Medical University and National Taiwan University Taipei, Taiwan.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Int J Clin Exp Pathol</MedlineTA>
<NlmUniqueID>101480565</NlmUniqueID>
<ISSNLinking>1936-2625</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004279">DNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.1.1.27</RegistryNumber>
<NameOfSubstance UI="D007770">L-Lactate Dehydrogenase</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000293">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015415">Biomarkers</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004279">DNA, Viral</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D018450">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020031">Epstein-Barr Virus Infections</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D004854">Herpesvirus 4, Human</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000472">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007770">L-Lactate Dehydrogenase</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008232">Lymphoproliferative Disorders</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000401">mortality</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000628">therapy</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010641">Phenotype</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012008">Recurrence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012074">Remission Induction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016176">T-Lymphocyte Subsets</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000276">immunology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000821">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" Type="Geographic" UI="D013624">Taiwan</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019562">Viral Load</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D055815">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">Epstein-Barr virus</Keyword>
<Keyword MajorTopicYN="N">T/natural killer-cell lymphoproliferation</Keyword>
<Keyword MajorTopicYN="N">Taiwan</Keyword>
<Keyword MajorTopicYN="N">hemophagocytic lymphohistiocytosis</Keyword>
<Keyword MajorTopicYN="N">infectious mononucleosis</Keyword>
<Keyword MajorTopicYN="N">systemic T/natural killer-cell lymphoproliferative disease</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>02</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2014</Year>
<Month>04</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>6</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>6</Month>
<Day>27</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>2</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24966953</ArticleId>
<ArticleId IdType="pmc">PMC4069894</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Blood. 2000 Jul 15;96(2):443-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10887104</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2001 Jul 15;98(2):280-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11435294</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2003 Feb 15;187(4):527-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12599068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hematol Pathol. 1990;4(4):189-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1963624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Pathol. 1994 Jun;144(6):1219-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8203462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pathol Int. 2008 Apr;58(4):209-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18324913</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Exp Pathol. 2013;6(1):105-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23236550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Surg Pathol. 2009 Aug;33(8):1230-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19561449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Lab Hematol. 2013 Oct;35(5):501-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23286298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Bone Marrow Transplant. 2011 Jan;46(1):77-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20498651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Pathol. 2011 Jun;64(6):536-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21490377</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2012 Jan 19;119(3):673-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22096243</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Pathol. 2012 Mar;65(3):278-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22247563</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hematol. 2008 Sep;83(9):721-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18626884</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>